Fluparoxan in male erectile disorder: a case report.

Abstract

During a protocol study for the efficacy of fluparoxan (a noradrenergic α(2)-antagonist) in depression, a positive effect on male erectile impotence has been observed in one case, with no important secondary effects. This result confirms the involvement of α(2)-antagonists in the handling of male impotence. The action on the erectile disorder appeared slightly before the antidepressive effect (2-3 weeks) and lasted for 6 weeks after the discontinuation of treatment, suggesting that the effects on impotence were not a mere reflection of the antidepressive action.

• Authors: O Le Bon, K Lion, P Verbanck, C Kornreich
• Journal: Journal of psychopharmacology (Oxford, England) (J Psychopharmacol) Vol. 9 Issue 1 Pg. 67-8 (Jan 1995) ISSN: 0269-8811 [Print] United States
• PMID: 22298696 (Publication Type: Journal Article)